Scarica l'app Stockscreener
20.55
0.10%
0.02
Dopo l'orario di chiusura:
21.25
0.70
+3.41%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CPRX Giù?
Forum
Previsione
Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie
What institutional flow reveals about Catalyst Pharmaceuticals Inc.Quarterly Trade Report & Safe Entry Zone Tips - newser.com
Is Catalyst Pharmaceuticals Inc. stock bottoming out2025 Pullback Review & Real-Time Volume Analysis Alerts - newser.com
Why hedge funds are buying Catalyst Pharmaceuticals Inc. stock2025 Volatility Report & Weekly Watchlist for Consistent Profits - Trung tâm Dự báo KTTV quốc gia
How Catalyst Pharmaceuticals Inc. stock benefits from strong dollarPortfolio Growth Summary & Capital Protection Trade Alerts - Trung tâm Dự báo KTTV quốc gia
How Catalyst Pharmaceuticals Inc. stock performs after earningsJuly 2025 Action & Reliable Entry Point Alerts - Trung tâm Dự báo KTTV quốc gia
Published on: 2025-10-17 22:48:25 - newser.com
First Week of June 2026 Options Trading For Catalyst Pharmaceuticals (CPRX) - Nasdaq
What macro factors could drive Catalyst Pharmaceuticals Inc. (CN2) stock higherWeekly Earnings Recap & High Win Rate Trade Alerts - newser.com
Why Catalyst Pharmaceuticals Inc. stock is favored by pension fundsWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Using flow based indicators on Catalyst Pharmaceuticals Inc.July 2025 Market Mood & Advanced Technical Analysis Signals - newser.com
How to use Fibonacci retracement on Catalyst Pharmaceuticals Inc.Market Risk Summary & Daily Market Momentum Tracking - newser.com
Catalyst Pharmaceuticals Shares Climb as New Drug Developments Spark Fresh Valuation Debate - Yahoo Finance
Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsBuy Signal & Weekly Breakout Opportunity Watchlist - newser.com
Catalyst Pharmaceuticals (CPRX): Assessing Valuation on Clinical Progress and Expanding Rare Disease Pipeline - Sahm
Assessing Catalyst Pharmaceuticals’ Value After Recent Positive FDA Ruling in 2025 - Sahm
Catalyst Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Should Catalyst Pharmaceuticals’ (CPRX) Share Buyback and New Data Prompt a Fresh Look at Its Strategy? - Sahm
Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term - sharewise.com
Using Ichimoku Cloud for Catalyst Pharmaceuticals Inc. technicalsWatch List & Consistent Growth Equity Picks - newser.com
Published on: 2025-10-10 04:19:27 - newser.com
Will earnings trigger a reversal in Catalyst Pharmaceuticals Inc.Portfolio Return Summary & Fast Gaining Stock Strategy Reports - newser.com
Catalyst Pharmaceuticals (NASDAQ:CPRX) Earns "Hold (C+)" Rating from Weiss Ratings - MarketBeat
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences - GlobeNewswire
Catalyst Pharmaceuticals to Present Research on Duchenne Muscular Dystrophy and Lambert Eaton Myasthenic Syndrome at Upcoming Scientific Conferences - Quiver Quantitative
3 Presentations: Catalyst Pharmaceuticals to present DMD & LEMS data at Oct 2025 conferences - Stock Titan
Real time breakdown of Catalyst Pharmaceuticals Inc. stock performance2025 Trading Volume Trends & Weekly High Potential Alerts - newser.com
Catalyst Pharmaceuticals Delivers Growth But Faces Narrow Pipeline Risk - Finimize
Published on: 2025-10-09 00:54:28 - newser.com
Lambert Eaton Myasthenic Syndrome Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Jacobus Pharmaceutical, Catalyst Pharmaceuticals - Barchart.com
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term - Yahoo Finance
What do Analysts Think About Catalyst Pharmaceuticals (CPRX)? - Insider Monkey
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Significant Upside Potential with 65% Growth Projection - DirectorsTalk Interviews
14 Biotech Stocks with High Potential - Insider Monkey
Will Catalyst Pharmaceuticals Inc. rebound enough to break evenTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Published on: 2025-10-06 05:08:49 - newser.com
Assessing Catalyst Pharmaceuticals (CPRX) Valuation After $200 Million Share Buyback Announcement - Yahoo Finance
Detecting price anomalies in Catalyst Pharmaceuticals Inc. with AIEarnings Summary Report & Long-Term Capital Growth Ideas - newser.com
A Closer Look at Catalyst Pharmaceuticals (CPRX) Valuation as Shares Remain Steady This Week - Sahm
Order flow analysis tools used on Catalyst Pharmaceuticals Inc.Weekly Trade Review & Capital Efficiency Focused Strategies - newser.com
Wealth Enhancement Advisory Services LLC Lowers Stock Position in Catalyst Pharmaceuticals, Inc. $CPRX - Defense World
Wall Street Zen Downgrades Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold - MarketBeat
Why Catalyst Pharmaceuticals Inc. (CN2) stock could break out in 2025July 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Catalyst Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):